When was Eden Research founded?

Eden Research was founded in 2003 and raised its 1st funding round 11 years after it was founded.

Where is Eden Research located?

Eden Research is headquartered in Cirencester, United Kingdom.

How many employees does Eden Research have?

As of Aug 31, 2026, the latest employee count at Eden Research is 28.

Is Eden Research a funded company?

Eden Research is a funded company, having raised an undisclosed amount across 3 funding rounds to date. The company's 1st funding round was a $***** Post IPO round, raised on Nov 21, 2014.

When was the latest funding round of Eden Research?

Eden Research's latest funding was a $***** Post IPO round on Oct 05, 2023, with participation from 0 investor.

Where does Eden Research rank among its competitors?

Eden Research ranks 155th amongst 2215 active competitors, of which 484 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was LifeMine Therapeutics, which secured $75M in Aug, 2026.

Who are the top competitors of Eden Research?

Eden Research's top competitors include Ginkgo Bioworks, Indigo and Antheia. Among them, LifeMine Therapeutics secured the most recent funding round in August, 2026.

Eden Research - 2026 Company Profile, Team, Funding, Competitors & Financials

Company Details

Sustainable biopesticides and plastic-free encapsulation technology for crop protection and animal health. The company focuses on providing sustainable solutions for foliar disease and insect control in open fields and greenhouses, soil pest management, and post-harvest shelf-life extension. It also offers solutions for animal health, including shampoos, conditioners, skin disease control, and odour control. Additionally, the company provides consumer products like head-lice treatment, deodorants, odour neutralisers, and fragrances. The company is committed to environmental, social, and governance principles, offering plastic-free alternatives and sustainable practices in the biopesticide industry.

Website: www.edenresearch.com/
Social
Email ID: *****@edenresearch.com

Key Metrics

Founded Year

2003

Location

Cirencester, United Kingdom

Stage

Public

Latest Funding Round

Post IPO, Oct 05, 2023, $*****

Investors

Massachusetts Biomedical Initiatives

Ranked

155^th among 2215 active competitors

Employee Count

28 as on Aug 31, 2026

Similar Companies

Indigo & 2815 more

Exit Details

Public

View Eden Research's full profile

Eden Research is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Eden Research Plc CIN: 3071324 , Germany, Active	Jun 21, 1995	-	5 (As on Jan 31, 2018)

Eden Research got listed on May 11, 2012.

Click here to take a look at Eden Research's IPO in detail

Eden Research has raised funding over 3 rounds. Its first funding round was on Nov 21, 2014. Eden Research has 1 institutional investor.

Here is the list of recent funding rounds of Eden Research:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Oct 05, 2023	7899128	Post IPO	8271105	4529453	5807179	3199612
Mar 30, 2016	8923699	Post IPO	4012897	5206222	8814031	4599682
Nov 21, 2014	6379185	Post IPO	9920444	9890693	3271529	9174938

Access funding benchmarks and valuations. Sign up today!

View details of Eden Research's funding rounds and investors

Eden Research's employee count trend

Eden Research has 28 employees as of Aug 26. Here is Eden Research's employee count trend over the years:

Uncover Eden Research's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Eden Research include Ginkgo Bioworks, Indigo and Antheia. Here is the list of Top 10 competitors of Eden Research, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Ginkgo Bioworks 2008, Boston (United States), Public	Autonomous labs for biotechnology, empowering scientists to design the living world	$796M	Viking Global Investors, T. Rowe Price & 53 others	81/100
2nd	Indigo 2013, Boston (United States), Series G	Provider of biological and sustainability solutions for the agriculture industry	$1.4B	Flagship Pioneering, Baillie Gifford & 26 others	78/100
3rd	Antheia 2013, Palo Alto (United States), Series C	Genetically engineered yeast cells to produce medicinal products	$176M	Viking Global Investors, ATHOS KG & 15 others	67/100
4th	Transcenta 2019, Suzhou (China), Public	Developer of antibody-based therapeutics	$205M	Lilly Asia Ventures, Sequoia Capital & 11 others	66/100
5th	Akeso 2012, Zhongshan (China), Public	Developer of antibody drug conjugates for the treatment of broad spectrum diseases	$195M	Orbimed, Sino Biopharmaceutical & 18 others	65/100
6th	Korro Bio 2018, Cambridge (United States), Public	Provider of RNA editing technologies to develop genetic medicines for rare and prevalent diseases	$4M	Cormorant Asset Management, Atlas Venture ... & 14 others	64/100
7th	Fermentalg 2005, Libourne (France), Public	Innovating with algae for sustainable solutions in nutrition and environmental impact	$30.3M	Demeter, Smalt Capital & 14 others	63/100
8th	Microban 1994, Huntersville (United States), Acquired	Antimicrobial and odor control technologies for durable product protection and freshness	$64.6M	TA Associates, UBS & 1 others	63/100
9th	LifeMine Therapeutics 2016, Watertown (United States), Series E	Developer of novel drugs from fungi via genome mining and recombinant overexpression	$563M	Fidelity Investments, 6 Dimensions Capital ... & 17 others	63/100
10th	Dewpoint Therapeutics 2018, Boston (United States), Series D	Developer of small molecule based therapeutics	$364M	Maverick Ventures, SoftBank Vision Fund & 16 others	62/100
155th	Eden Research 2003, Cirencester (United Kingdom), Public	Sustainable biopesticides and plastic-free encapsulation technology for crop protection and animal health	-	Massachusetts Biomedical Initiatives	46/100